ZIP Insider Sale: David Travers Disposes of 18,793 Shares via 10b5-1 Plan

Rhea-AI Filing Summary

David Travers, President of ZipRecruiter, Inc. (ZIP), reported an insider sale on Form 4. The Form 4 shows that on 09/18/2025 Mr. Travers disposed of 18,793 shares of Class A common stock at a weighted average price of $5.3021 per share under a Rule 10b5-1 trading plan adopted on September 13, 2024.

After the reported sale, the filing shows Mr. Travers beneficially owns 1,139,987 shares. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/22/2025 and includes an undertaking to provide detailed per-transaction pricing within the disclosed price range of $5.215 to $5.355 upon request.

Positive

• Transaction was executed under a Rule 10b5-1 trading plan, providing an affirmative defense and procedural clarity
• Filing discloses a weighted average price ($5.3021) and a price range ($5.215–$5.355) and offers to provide per-trade details on request
• Form 4 was executed and signed (by attorney-in-fact), demonstrating compliance with reporting requirements

Negative

• Reporting person disposed of 18,793 shares, reducing direct beneficial ownership to 1,139,987 shares
• Insider selling is disclosed publicly, which investors may interpret as insider disposition even if pre-planned

Insights

Securities Analyst

TL;DR: Insider sale of 18,793 shares via a pre-established 10b5-1 plan; holdings remain material at 1,139,987 shares.

The reported sale was executed pursuant to a Rule 10b5-1 trading plan adopted September 13, 2024, which provides an affirmative defense against insider trading claims when properly structured. The transaction reduced direct beneficial ownership to 1,139,987 shares. The filing discloses a weighted average sale price of $5.3021 and a price range of $5.215 to $5.355, and the reporting person has committed to provide per-trade price details on request. From a market-impact perspective, the quantity sold is small relative to total outstanding shares for most public companies, but the sale is a notable disclosure for investors tracking insider activity.

Corporate Governance Expert

TL;DR: Transaction follows standard compliance procedures using a 10b5-1 plan; filing properly executed by attorney-in-fact.

The Form 4 indicates proper governance mechanics: the sale was executed under a documented 10b5-1 plan and the filing includes explanatory notes and an undertaking to provide detailed trade pricing. The signature by an attorney-in-fact is present and dated, satisfying filing formalities. The disclosure enhances transparency about insider dispositions but does not, by itself, indicate a governance breach or regulatory concern based solely on the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TRAVERS DAVID

(Last) (First) (Middle)

C/O ZIPRECRUITER, INC.

3000 OCEAN PARK BLVD., SUITE 3000

(Street)

SANTA MONICA CA 90405

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIPRECRUITER, INC. [ ZIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/18/2025		S(1)		18,793	D	$5.3021(2)	1,139,987	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2024.

2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.215 to $5.355 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Remarks:

	/s/ Ryan Sakamoto, Attorney-in-Fact for Reporting Person	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did ZIP insider David Travers report on Form 4?

The Form 4 reports that David Travers sold 18,793 shares of Class A common stock on 09/18/2025.

At what price were the ZIP shares sold by the insider?

The filing reports a weighted average price of $5.3021 and states individual sale prices ranged from $5.215 to $5.355 per share.

Was the sale part of a prearranged plan for ZIP insider sales?

Yes. The transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2024.

How many ZIP shares does David Travers beneficially own after the reported sale?

After the reported transaction, the filing shows Mr. Travers beneficially owns 1,139,987 shares.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Ryan Sakamoto, Attorney-in-Fact for the reporting person on 09/22/2025.

Will detailed per-trade prices be provided?

The reporting person has undertaken to provide to the issuer, any security holder, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the disclosed range.